Skip to main content
. 2020 Jul 2;11:603. doi: 10.3389/fgene.2020.00603

TABLE 3.

Mendelian randomization results.

BMI WHR WHRadjBMI



Outcome Method nSNP OR (95% CI) P nSNP OR (95% CI) P nSNP OR (95% CI) P
T2DM
IVW 446 2.741(2.421,3.104) 6.12E-57 276 3.12(2.653,3.668) 3.87E-43 237 1.993(1.704,2.33) 5.59E-18
MR–PRESSO (Outlier-corrected) 433 3.064(2.871,3.271) 9.15E-123 254 3.543(3.164,3.968) 2.67E-60 211 2.117(1.908,2.35) 3.06E-32
Multivariable MR 842 3.338(2.625,4.246) 1.47E-20 672 2.887(2.54,3.281) 3.66E-50 633 2.105(1.755,2.524) 8.57E-15
Weighted median 446 2.835(2.576,3.12) 6.18E-101 276 2.769(2.43,3.156) 1.02E-52 237 1.983(1.764,2.229) 1.74E-30
MR–Egger 446 2.829(2.042,3.918) 9.28E-10 276 1.894(1.109,3.234) 0.020 237 1.699(1.087,2.656) 0.0201
HOMA-IR
IVW 447 1.221(1.187,1.255) 6.69E-44 278 1.203(1.155,1.252) 4.03E-19 238 1.127(1.088,1.167) 3.69E-11
MR–PRESSO (Outlier-corrected) 446 1.223(1.19,1.258) 5.15E-38 278 NA NA 238 NA NA
Multivariable MR 723 1.294(1.187,1.411) 1.29E-08 554 1.192(1.148,1.237) 1.28E-18 529 1.197(1.134,1.262) 1.61E-10
Weighted median 447 1.214(1.161,1.27) 2.79E-17 278 1.18(1.114,1.251) 2.25E-08 238 1.128(1.07,1.188) 6.90E-06
MR–Egger 447 1.255(1.165,1.352) 4.41E-09 278 1.175(1.024,1.348) 0.022 238 1.199(1.089,1.32) 2.72E-3
HbA1c
IVW 446 1.054(1.04,1.068) 4.99E-14 280 1.075(1.056,1.095) 1.13E-14 239 1.061(1.042,1.08) 3.85E-11
MR–PRESSO (Outlier-corrected) 441 1.05(1.036,1.064) 9.67E-13 278 1.075(1.056,1.094) 4.41E-14 235 1.054(1.037,1.072) 1.61E-09
Multivariable MR 735 1.076(1.031,1.123) 8.11E-3 569 1.074(1.055,1.093) 5.04E-14 543 1.065(1.038,1.094) 3.79E-06
Weighted median 446 1.06(1.04,1.081) 3.83E-09 280 1.07(1.044,1.096) 4.60E-08 239 1.059(1.034,1.085) 2.08E-06
MR–Egger 446 1.06(1.024,1.099) 0.001 280 1.062(0.998,1.131) 0.058 239 1.084(1.033,1.137) 0.001
Fasting insulin
IVW 449 1.202(1.173,1.231) 4.73E-50 281 1.193(1.153,1.234) 2.28E-24 240 1.102(1.068,1.136) 6.37E-10
MR–PRESSO (Outlier-corrected) 446 1.198(1.17,1.226) 4.55E-42 280 1.201(1.162,1.241) 3.45E-23 237 1.108(1.077,1.141) 2.80E-11
Multivariable MR 742 1.298(1.204,1.4) 6.62E-11 574 1.184(1.147,1.223) 5.81E-23 548 1.179(1.125,1.235) 2.18E-11
Weighted median 449 1.213(1.168,1.26) 1.54E-23 281 1.187(1.136,1.24) 1.41E-14 240 1.129(1.083,1.177) 1.03E-08
MR–Egger 449 1.209(1.134,1.289) 1.06E-08 281 1.18(1.052,1.324) 0.005 240 1.2(1.105,1.304) 2.29E-05
Fasting glucose
IVW 449 1.073(1.048,1.099) 4.53E-09 281 1.087(1.054,1.12) 8.78E-08 240 1.039(1.012,1.067) 0.004
MR–PRESSO (Outlier-corrected) 446 1.083(1.059,1.107) 7.61E-12 278 1.098(1.067,1.13) 7.19E-10 239 1.044(1.017,1.072) 0.001
Multivariable MR 742 1.025(0.947,1.109) 0.546 574 1.067(1.034,1.102) 8.18E-05 548 1.019(0.971,1.069) 0.443
Weighted median 449 1.077(1.041,1.114) 1.88E-05 281 1.092(1.048,1.138) 2.60E-05 240 1.058(1.017,1.101) 0.005
MR–Egger 449 1.067(1.002,1.136) 0.043 281 1.091(0.984,1.209) 0.098 240 1.075(1.001,1.155) 0.049

WHR, waist-to-hip ratio; BMI, body mass index; WHRadjBMI, waist-to-hip ratio adjusted for body mass index; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; SBP, systolic blood pressure; DBP, diastolic blood pressure; T2DM, type 2 diabetes; SD, standard deviation; HOMA-IR, homeostasis model assessment of insulin resistance; HbA1c, hemoglobin A1c; nSNP, numbers of the SNPs (instrumental variable) used in Mendelian randomization; IVW, inverse-variance weighted; MR–egger, Mendelian randomization–Egger regression; MR–PRESSO, Mendelian randomization pleiotropy residual sum and outlier method; OR, odds ratio; CI, confidence interval.